15-50997734-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000261842.10(AP4E1):āc.2755A>Gā(p.Met919Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000878 in 1,613,886 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000261842.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4E1 | NM_007347.5 | c.2755A>G | p.Met919Val | missense_variant | 18/21 | ENST00000261842.10 | NP_031373.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4E1 | ENST00000261842.10 | c.2755A>G | p.Met919Val | missense_variant | 18/21 | 1 | NM_007347.5 | ENSP00000261842 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00461 AC: 702AN: 152210Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00127 AC: 318AN: 250798Hom.: 4 AF XY: 0.000959 AC XY: 130AN XY: 135596
GnomAD4 exome AF: 0.000487 AC: 712AN: 1461558Hom.: 6 Cov.: 31 AF XY: 0.000395 AC XY: 287AN XY: 727090
GnomAD4 genome AF: 0.00463 AC: 705AN: 152328Hom.: 7 Cov.: 32 AF XY: 0.00424 AC XY: 316AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 25, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 22, 2023 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 26, 2016 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Sep 01, 2018 | - - |
Stuttering, familial persistent, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
AP4E1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary spastic paraplegia 51 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at